Zeeuws Investment Fund
  • ABOUT US
    • ZIF
    • FUND MANAGER
  • CRITERIA
  • INVESTMENTS
    • TOXYS
    • DOVIDEQ MEDICAL
    • INNO4LIFE
    • MAGNETIC
    • MIMETAS
    • EAGLET EYE
    • SOTERIA MEDICAL
    • ILLUXTRON
  • NEWS
  • CAREERS
  • CONTACT
  • DUTCH

MIMETAS HAS RECEIVED A SECOND INNOVATION CREDIT

11/22/2017

 
Picture
Mimetas has received a second Innovation Credit of 2 million euro during the visit of the State Secretary for Economic Affairs and Climate (EZK). Mimetas uses this support for the further development of personalized medicine: for example a tool that helps the oncologist in choosing the most effective treatment of different cancers. Such a tool will save the health care sector costs and the patient will have fewer side effects of ineffective treatment.

Partly thanks to the government support through the Eurostar program and the Innovation Credit, the company grew from 2 to over 50 employees. Mimetas also opened a branch in the US and the company entered into a new partnership with Japan. Co-director Jos Joore: “Medical innovations such as Mimetas are not possible without support of the government.” 


You can read the full press release (in Dutch) here.
​Click here for more information about Mimetas.


Comments are closed.

    ARCHIVES

    March 2020
    April 2018
    November 2017
    September 2017
    May 2017
    January 2017
    September 2016
    March 2016
    February 2016
    December 2015
    November 2015
    September 2015
    July 2015
    June 2015
    February 2014
    January 2014
    January 2013

    CATEGORIES

    All
    DOVIDEQ Medical
    Eaglet Eye
    Illuxtron
    Inno4Life
    MAGnetIC
    MIMETAS
    Soteria Medical BV
    Toxys

ZEEUWS INVESTMENT FUND
Edisonweg 41a | 4382 NV | Vlissingen | The Netherlands | + 31 (0)6 24810367 | johan@zeeuwsinvesteringsfonds.nl | Privacy policy